Other

Dataset Information

0

The effect of STAG2 loss in Ewing sarcoma


ABSTRACT: SMC1a HiChIP was performed for the Ewing sarcoma cell line A673 under two conditions: 1) cells treated with non-targeting CRISPR Cas9 guides or 2) STAG2-targeting CRISPR Cas9 guides. Cells treated for gene editing were clonally selected and confirmed to either express STAG2 (control condition) or have loss of STAG2 expression (STAG2 loss condition). For the control condition, we used the cell clones A673.sgNT-1c4 and the STAG2 knockout clone A673.sgSTAG2-1c6. HiChIP was performed for each clone in duplicate.

ORGANISM(S): Homo sapiens

PROVIDER: GSE113100 | GEO | 2021/05/14

REPOSITORIES: GEO

Similar Datasets

2021-04-29 | GSE133227 | GEO
2021-04-29 | GSE133154 | GEO
2021-04-29 | GSE132966 | GEO
2021-04-29 | GSE156650 | GEO
2015-09-16 | E-GEOD-72369 | biostudies-arrayexpress
2015-09-16 | E-GEOD-72368 | biostudies-arrayexpress
2020-12-13 | GSE154086 | GEO
2021-04-29 | GSE142162 | GEO
| PRJNA550418 | ENA
2021-02-23 | GSE153575 | GEO